I made the following 2 posts on another site as many new

New Post Public Reply Private Reply Replies (0) Message Board
petemantx
353
I made the following 2 posts on another site as many new members were coming to the board and I was sure most had no real clue as to "naked shorts" so I wrote the following. I had not posted them here as I know this board has mostly longs quite familiar with this subject but a friend asked me to post them here and I am gladly following his suggestion:

There is no way to verify "naked" shorts. Very quickly, naked shorts are when market makers (MMs) "sell" shares when there are no shares available for sale. They do this by supposedly "borrowing" shares from legal stockholders for which they pay a fee but how many of you have heard from your brokerage that they are "borrowing" your shares? Rest assured, brokerages are making an illegal FORTUNE every year lending out (for a fee) shares held by legal stockholders without the stockholders permission or knowledge of these naked shorts.( Do you know if your shares are being lent out for a fee? Have you been paid as you are supposed to be for this right?) But back to naked shorts, if those sell orders never materialize or "borrowed" shares are unavailable fro which the brokerage has already "sold" ghost or air shares (other names for naked shorts), the MMs are left with many orders sold that do not have a corresponding amount of shares offered to balance them out. Over time that can lead to a VAST amount of such "air" shares on the market. Overstock Corp found they had over DOUBLE the legal shares issued being traded on the market compared to their legally issued shares. Result is MMs can walk down the price to next to nothing (as .05 cents for IPIX shares) even though no legal stockholders are putting up shares for sale because they know by trading amongst themselves (due to T+2 trading) they can keep the "air" shares rotating between themselves and never have to square them up. That is why they are naked and non-transparent and why many who only throw out the "legal" short numbers to support their views are laughing behind their backs. They know naked shorts are one of the biggest money makers going for brokerages and illegal trading concerns (usally all being done by sophisticated mathematical algorithms). For those not familiar with shorts, the "legal" shorts are no problem and those investing in them are not looked down on by any long investor. I am only condemning "naked" short shares.

Would like to know any other reasoning as to how IPIX can be so under priced based on the projected value of its 2 drugs if both prove to be commercial, why there is so much and so viral an effort on many sites to denigrate the stock, why so many waste time deriding it when they have no skin in the game, how there can be such a disconnect between the science and lack of offers to date, why 240MM is thought to be such as outlandish share total when the revenue streams of the two IPIX drugs could be over $200B/yr, etc, etc. Is the potential of IPIX as large as some say - just do the numbers for the individual markets IPIX is going after. The potential is so large most true longs never give out their true estimates as to future share price as they would look to be beyond belief, but again, what if IPIX drugs can capture 20% of the $200B/yr market streams and IPIX gets a 15% royalty on all sales? That equates to $6B/yr of royalties with an employment of less than 10. Yearly costs would be minimal so if one takes $6B and divides by 400MM (I am going sky high for total shares to be very conservative) you would still get a yearly dividend of near $15/yr). That is $1.5MM /yr in dividends for every 100K shares owned. Note I have not even mentioned share price - what would one expect the share price to be if the dividends are $15/yr per share? One can thus see the numbers get so stupidly large nobody would believe them - BUT THEY ARE THERE IN ALL POSSIBILITY.

The govt testing of Brilacidin will be a chance for govt and the medical world in general to get a much better idea of the new branch of medicine, defensin mimetics, de novo drugs, that many feel will change the face of medicine. The old hit-and-miss method of arriving at new drugs is dead, super computers are the face of new drug candidates, and Brilacidin has been noted as the best of this new class of medicine. Willing to wait the next few weeks to see if Brilacidin excites the ultra-lab crowd (meaning the government) and the academic crowd (meaning the university testing B for corona) as to its many, many merits and its astonishing safety profile that has shown no negative side effects to date (if Brilacidin given in the correct dosage).

If it walks like a duck, quacks like a duck,......
=====================================================

Below post is in response to a question someone asked me in regards to the above post.

]
This is why you see so many yelling for a T+0 trading requirement for ALL stock trades. This means ALL trades must be squared up each day so it is known who bought and sold all shares. This is possible thru chain block technology, where no data can be rearranged in the files. All "naked" shorting would end and there would be a much more level playing field for all investors. MMs couldn't pass around the "naked" shorting, they would have to square up DAILY.

I have no source to reference, but I do remember seeing once that the vast majority of JPM and Sachs trading profits come from the "black pool", that realm of trading that has no transparency and IMO that is the naked shorting pool. Also, you see these hedge funds that make massive amounts of money. They also are major players in trying to drive start ups into bankruptcy. When a short has an open position in a company that goes bankrupt, they get to keep the funds they bought from their "sale" of shares TAX FREE as, once bankrupt, they never have to complete the trade by purchasing shares. That is why they work so hard to drive companies into bankruptcy. I hope some are realizing the treachery retail investing is up against these days, much less the computerized systems that are flipping shares incessantly to make a little profit on a massive amount of trades. Kind of like collecting all the pennies left over at the end of the day from all retail stores in the country.

The only current watchdog (LOL) for retail traders is FINRA and guess who funds FINRA? That's right, the very same MMs, brokerage houses, hedge funds, and large financial concerns who are so overwhelmingly protected by the system. The ol' proverbial fox guarding the chicken house. FINRA certainly isn't going to bite the hand that feeds them. They do have some window dressing fines from time to time, but when the penalty is but a percentage point or so of the profits, its just part of the cost of doing business. Only thing that would stop the illegality is if a large number of execs running these companies were thrown into jail for lengthy jail terms. But look at the POS Ponzi guy from NY who stole BILLIONS, he is looking to get out (there is actually a chance he may get out) now as he claims he is dying of cancer. Who gives a F if he dies in prison? I would hope he dies in the greatest of pain for the longest time possible for what he did to tens of thousands of families who put their trust in him to handle their retirement savings.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 2

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
Chattanooga: A New Epicenter for Quantum Computing

Updated Category News Views 4

Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...

Continue Reading
Quay Dominates 2026 Sunglasses Review for Variety

Updated Category News Views 2

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...

Continue Reading
Fly High: Encouraging Girls to Soar into Aviation

Updated Category News Views 4

The Sky's Not the Limit—It's Just the Beginning Step aside, conventional paths. There's a flight school owner in Sedona, Arizona, making waves by encouraging girls to swap their land-bound dreams for sky-high aspirations. This International Girls in Aviation Day, Michelle Smith wants young dreamers to know their possibilities span as wide as the open sky. Defying...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 2

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
Mental Health Day Celebrations Set for October in NYC

Updated Category News Views 7

Mental Health Steals the October Spotlight In the bustling streets of New York City, October is about to get a mental health makeover. Project Healthy Minds is putting the pedal to the metal with their fourth annual World Mental Health Day Gala on October 8th, followed by the world’s largest mental health festival on October 10th. These events, held at Spring Studios,...

Continue Reading
Ensuring Your Radon Mitigation System Stays Effective

Updated Category News Views 3

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Continue Reading
Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 1

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading
AI Agents Challenge Product Governance Models

Updated Category News Views 7

AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...

Continue Reading

Top 5 Most Recently Viewed Articles

Mark Cuban's Timeless Wisdom on Managing Credit Card Debt

Updated Category News Views 267

Credit card debt became a mounting problem for many consumers, hitting a staggering $1.14 trillion recently. This hefty figure marked an alarming increase of $27 billion in just one quarter—definitely not the kind of trend any trader or financial guru wants to see. Traders were buzzing about this spike back then, grappling with what it meant for consumer spending and...

Continue Reading
Tachyus Partners with Anschutz for Enhanced Carbon Management

Updated Category News Views 164

Tachyus Partners with Anschutz Exploration Tachyus has announced an exciting collaboration with Anschutz Exploration to implement Aurion, its innovative platform designed for efficient greenhouse gas (GHG) emissions management. This contract marks a significant step for Anschutz, aiming to establish a comprehensive GHG baseline while effectively monitoring and forecasting...

Continue Reading
Sampo plc Enhances Share Buyback Program: Key Updates

Updated Category News Views 110

Sampo plc's Share Buyback Program: An Overview Sampo plc has made significant strides in its share buyback initiatives. As shareholders, it is essential to stay updated on how these developments may affect your investments. Recently, the company disclosed its activities regarding A share repurchases, which offer insights into its strategic approach in the market. Details...

Continue Reading
Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH

Updated Category News Views 373

Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...

Continue Reading
Innovative Breakthrough in Cancer Treatment with NX-5948

Updated Category News Views 287

Exciting Clinical Results for NX-5948 In a noteworthy development, Nurix Therapeutics, Inc. has shared promising results from their ongoing Phase 1a/1b clinical trial of NX-5948, aimed at treating patients with relapsed or refractory Waldenstrom's macroglobulinemia (WM). In this trial, NX-5948, a targeted degrader of Burton's tyrosine kinase (BTK), demonstrated...

Continue Reading